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WS21.1 The genetic basis of Pseudomonas aeruginosa
pathoadaptation to the airways of cystic ﬁbrosis patients
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Objectives: Advances in genome sequencing have made it feasible to sequence
multiple genomes of the same lineage of bacterial pathogens as they evolve in
their human hosts. Nonetheless, only little is known about how evolution processes
compare between genotypic different lineages of the same pathogenic species when
they evolve within their human hosts.
Methods: Here, we analyze the genomes of 474 isolates of P. aeruginosa sampled
from 34 young Danish CF patients. Our phylogenetic analysis reveals the patients
to be infected by 53 different clone types of P. aeruginosa, and for 36 of the
clone types we sequenced multiple longitudinal isolates, enabling us to decipher
the within-host evolutionary history of each of these lineages.
Results:We found the 36 lineages to exhibit mutational convergence in 56 pathoad-
aptive genes (genes mutated in >5 clone types), in which the host environment
imposed a selection for mutations. The pathoadaptive genes were related to motility,
antibiotic resistance, remodeling of regulatory networks, bioﬁlm formation, and
extracellular virulence factors. Furthermore, our results show that mutation of
downstream transcriptional regulators was contingent upon the mutation of upstream
regulators in the same regulatory network.
Conclusion: In conclusion, we have identiﬁed adaptive trajectories generic to
P. aeruginosa in the CF environment, and elucidated how early mutations predict
later evolutionary events. Knowledge of pathoadaptive mutations and evolutionary
contingency may help prediction of bacterial persistence and development of future
therapeutic targets against the infection.
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Chronic respiratory infection with P. aeruginosa is a signiﬁcant cause of morbidity
in people with cystic ﬁbrosis. P. aeruginosa establishes chronic lung infection in part
through genotypic and phenotypic adaptations. One of these may be inactivating
mutation of the quorum sensing gene lasR. LasR mutants are common in CF
secretions, have a growth advantage with nutrients found in CF sputum, and may
be a marker for poor prognosis. Little is known about the breadth of mutations
that occur in this gene and their relationships to LasR functionality. We set out
to deﬁne the range of mutations in a collection of CF P. aeruginosa isolates
and characterize their impact on LasR functions, including signal binding and
transcriptional regulation. We analyzed the lasR gene from 2683 individual isolates
from children in the Early Pseudomonas Infection Control (EPIC) study, of which
2583 yielded lasR gene sequences. A total of 581 isolates (22%) possessed a lasR
coding change, a frequency consistent with prior studies. This collection contained
172 unique mutations, of which 115 were either missense or nonsense mutations.
Speciﬁc regions in both the signal and DNA binding domains of LasR were enriched
for mutants. Finally we found only weak associations between these lasR mutations
and phenotypes identiﬁed previously among LasR-null P. aeruginosa, including
colony morphology and protease and pigment production, suggesting that some of
these variants retain partial LasR activity. We anticipate that our full functional
analysis will provide information about the structure of LasR and some of the
selective pressures affecting quorum sensing in chronic CF lung infections.
WS21.3 In vitro non-mucoid to mucoid phenotypic switching in
clinical isolates of Pseudomonas aeruginosa is induced by
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Objectives: Nebulised mannitol is a novel intervention that promotes airway
clearance. It is therefore important to assess the effects (if any) on altering baseline
CF physiology with mannitol on co-habiting bacterial pathogens. The aim was
therefore to examine in vitro the effect of mannitol on Pseudomonas aeruginosa
[PA] and other CF bacteria to switch from a non-mucoid to a mucoid phenotype.
Methods: 64 CF clinical isolates were examined, i.e. PA (n = 51), Burkholderia
cenocepacia (n = 6), P. putida (n = 4), Stenotrophomonas maltophilia (n = 2) and
Pseudomonas sp. (n = 1). In selecting these, any with a previous history of mucoidy
were excluded and none of the isolates examined had ever demonstrated mucoidy.
All isolates were pre-screened for mucoidy and any which were mucoid were
excluded. Isolates were cultured on Nutrient Agar [NA] and on NA + 4% [w/v]
mannitol for 48h at 37oC. Following this, they were examined for the presence of
a mucoid phenotype.
Results: 5/51 (9.8%) PA organisms exhibited a switch in phenotype from non-
mucoid to mucoid, whereas none of the other organisms examined showed any
switch in phenotype. This mucoidy was lost when those switching PA organisms
were re-cultured onto nutrient agar without mannitol and mucoidy was re-instated,
when subsequently recultured back onto medium containing 4% mannitol. Such
switching phenomenon was not observed when repeated using sodium chloride. To
date, all studies have been in vitro and we are uncertain as to what happens in the
in vivo scenario.
Conclusion: Such switching to the mucoid state in PA could be important for
bacterial virulence, antibiotic penetration/treatment, as well as microbiological
reporting.
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Since its emergence in the mid 1990s, we have studied the transmissible Liverpool
Epidemic Strain (LES), a CF-adapted clone that is widespread amongst CF patients
in the UK and has been reported in North America. We have analysed populations of
the LES from the sputa of multiple chronically infected adult CF patients. Following
the establishment of a chronic infection in the lungs of CF patients, populations
of P. aeruginosa LES adapt and diversify due to mutation. Hence, multiple single
strain isolates from the same patient sample can exhibit diversity in phenotypes
such as quorum sensing, mucoidy and antibiotic resistance.
Using phenotypic analysis and whole genome sequencing we have compared LES
populations between patients and followed population changes over time, including
during periods of exacerbation. Our data suggest that populations are highly variable
between patients and dynamic within patients over time periods of several months.
In addition, we have analysed archived, historical isolates and isolates from multiple
geographical locations to determine the distribution of speciﬁc mutations identiﬁed
using genome sequencing. These studies give us insights into transmission pathways
within and between CF units.
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